Abstract
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetitive patterns of behavior, interests, or activities and often intellectual disabilities. ASD has a number of prevalent co-morbidities, such as sleep disorders, attention deficit/hyperactivity disorder and epilepsy. No effective treatment for the core symptoms of ASD is currently available. There is increasing interest in cannabinoids, especially cannabidiol (CBD), as monotherapy or add-on treatment for the core symptoms and co-morbidities of ASD. In this review we summarize the available pre-clinical and clinical data regarding the safety and effectiveness of medical cannabis, including CBD, in young ASD patients. Cannabidiol seems to be a candidate for the treatment of ASD. At present, however, there are no convincing pre-clinical or clinical data showing efficacy and safety of cannabinoid treatment in ASD patients.
Citations
Nov 5, 2019·Journal of Analytical Toxicology·Tory R SpindleRyan Vandrey
Sep 13, 2019·Scientific Reports·Hyong Woo ChoiDaniel F Klessig
Jan 26, 2020·International Journal of Molecular Sciences·Pierangelo CifelliEleonora Palma
Nov 13, 2019·Current Pharmaceutical Design·Shogo NakashimaTatsuya Akutsu
Oct 24, 2019·CNS & Neurological Disorders Drug Targets·Eric Murillo-RodríguezRené Drucker-Colín
Mar 11, 2020·BMJ Open·Daryl EfronKatrina Williams
Jun 3, 2020·The Annals of Pharmacotherapy·Shannon IngletWhitney Mortensen
Jun 2, 2020·British Journal of Clinical Pharmacology·Daryl EfronKatrina Williams
Aug 25, 2019·Science China. Life Sciences·Junchi ZhangJingshan Shen
Jan 29, 2019·Frontiers in Pharmacology·Dana BarchelMatitiahu Berkovitch
Aug 23, 2020·Brain Sciences·Laura Fusar-PoliEugenio Aguglia
Oct 31, 2019·BMC Psychiatry·Rumi AgarwalMarlaina Maddux
Aug 15, 2019·Neurotoxicology·Stefania BonaccorsoFabrizio Schifano
Dec 29, 2020·Neuroscience and Biobehavioral Reviews·Emilia CarboneViviana Trezza
Sep 22, 2020·Journal of Affective Disorders·Andrea EscelsiorMario Amore
Feb 6, 2021·ACS Chemical Neuroscience·Wojciech ChrobakInna Ermilova
Nov 17, 2020·Frontiers in Cellular Neuroscience·Jon DelaCuesta-BarrutiaAmaia M Erdozain
Dec 17, 2020·International Journal of Molecular Sciences·Ana Rita GomesChris P Reutelingsperger
Feb 9, 2021·Frontiers in Pharmacology·Albert BatallaMatthijs G Bossong
Feb 23, 2021·Frontiers in Pharmacology·Franciele F ScaranteAlline C Campos
Mar 2, 2021·Frontiers in Psychiatry·Rafael M BitencourtElisaldo A Carlini
Mar 11, 2021·Journal of Psychiatric Research·V NezgovorovaE Hollander
Mar 31, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M Díaz-CanejaC Arango
Apr 25, 2021·Seminars in Pediatric Neurology·Autumn S Ivy, S M Standridge
May 26, 2021·Journal of Translational Medicine·Aymen H SadakaCraig F Ferris
Aug 26, 2021·Cannabis and Cannabinoid Research·Richard HoldmanAlexandra Elyse Contreras
Aug 28, 2021·Genes·William Fyke, Milen Velinov
Sep 11, 2021·Journal of Autism and Developmental Disorders·Majd Al-SoleitiChristopher J Keary
Sep 14, 2021·Frontiers in Behavioral Neuroscience·J S KaplanB Predovich
Oct 15, 2021·Translational Psychiatry·Shani PolegDaniel Offen
Oct 15, 2021·Journal of Neurodevelopmental Disorders·Patricia S PirbhoyDevin K Binder